Assessment of safety and efficacy against Bordetella pertussis of a new tetanus-reduced dose diphtheria-acellular pertussis vaccine in a murine model

Contact us

• Submission enquiries: bmcinfectiousdiseases@biomedcentral.com
• General enquiries: ORSupport@springernature.com